Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial

Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    - Revision history updated: v3.4.3 added and v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-11T16:41:18.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed prior non-critical notices including a government funding/operating status message (Revision: v3.4.1).
    Difference
    0.3%
    Check dated 2026-02-11T03:14:13.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the record version updated from v3.4.0 to v3.4.1, with no changes to study details or record content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T01:42:17.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The Record History page now includes a glossary option and color-coded change highlights (green for additions, red for deletions) with an updated revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-01-28T00:28:29.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added to the history, and v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:43:22.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Footer updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T10:22:12.000Z thumbnail image

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.